HAO offering history
Every offering-related filing in Haoxi Health Technology Ltd’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 104 filings back to Feb 15, 2023.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 13, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 12, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 23, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 13, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 10, 2025 | F-3/A → | REGISTERED | F-3/A registration — capacity to sell shares, not a sale yet |
| May 30, 2025 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Sep 20, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 19, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Sep 19, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 12, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Aug 28, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Aug 12, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jul 31, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jul 24, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jul 18, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jul 15, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jun 13, 2024 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Jan 29, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jan 25, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 23, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Dec 15, 2023 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Nov 22, 2023 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Oct 24, 2023 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Sep 19, 2023 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Aug 25, 2023 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
HAO offering FAQ
When did HAO last execute an offering?
Per SEC filings, Haoxi Health Technology Ltd's most recent priced offering document is a 424B5 filed 2026-07-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did HAO last announce or register an offering?
The most recent registration is a F-3/A filed 2025-06-10. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.